The Patent Finder

Gene Techno Science Co., Ltd.

Also on record
Records under this name other than the patents Gene Techno Science Co., Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.

Showing 1 to 10 of 10 · Back to Gene Techno Science Co., Ltd.

PatentTitleStatus Expires Confidence
US 10,544,466Method for diagnosing and treating cancer brain metastasis and drug delivery system for enabling passage through blood-brain barrier
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 7,595,045Anti-α9 integrin antibody and the use thereof
Term ended
Term ended Mar 22, 2026 · From the USPTO record
Term endedTerm ended Mar 22, 2026From the USPTO record
US 8,372,639Anti-human α9 integrin antibody and use thereof
Lapsed on the fee record
Ended Feb 12, 2025 · From the USPTO record
Lapsed on the fee recordEnded Feb 12, 2025From the USPTO record
US 10,774,312Method for producing frozen mesenchymal cells and method for producing implantable therapeutic member
Lapsed on the fee record
Ended Sep 15, 2024 · From the USPTO record
Lapsed on the fee recordEnded Sep 15, 2024From the USPTO record
US 8,221,754Antihuman α9 integrin antibody and use of the same
Lapsed on the fee record
Ended Jul 17, 2024 · From the USPTO record
Lapsed on the fee recordEnded Jul 17, 2024From the USPTO record
US 8,821,863Humanized anti-α 9 integrin antibodies and the uses thereof
Lapsed on the fee record
Ended Sep 2, 2022 · From the USPTO record
Lapsed on the fee recordEnded Sep 2, 2022From the USPTO record
US 8,735,552Generation, expression and characterization of the humanized K33N monoclonal antibody
Lapsed on the fee record
Ended May 27, 2022 · From the USPTO record
Lapsed on the fee recordEnded May 27, 2022From the USPTO record
US 8,617,829Humanized antibodies specific for amino acid sequence RGD of an extracellular matrix protein and the uses thereof
Lapsed on the fee record
Ended Dec 31, 2021 · From the USPTO record
Lapsed on the fee recordEnded Dec 31, 2021From the USPTO record
US 8,614,296Humanized antibodies specific for amino acid sequence RGD of an extracellular matrix protein and the uses thereof
Lapsed on the fee record
Ended Dec 24, 2021 · From the USPTO record
Lapsed on the fee recordEnded Dec 24, 2021From the USPTO record
US 8,461,310Anti-Adam-15 Antibodies and Utilization of the Same
Lapsed on the fee record
Ended Jun 11, 2021 · High confidence
Lapsed on the fee recordEnded Jun 11, 2021High confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited